AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
6 registrations across 4 African markets— 4 active
Markets with DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Dolutegravir, Lamivudine and Tenofovir Disoproxil Fumarate Tablets | 🇷🇼Rwanda | MICRO LABS LIMITED | active | Oct 2029 |
| DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TABLET 50MG,300MG & 300MG TABLETS | 🇷🇼Rwanda | LUPIN Limited | active | Aug 2029 |
| DOLUTEGRAVIR/LAMIVUDUNE/TENOFOVIR DISOPROXIL FUMARATE TABLETS (Each tablet contains Dolutegravir, Lamivudine and Tenofovir Disoproxil Fumarate 50mg/300mg/300mg) | 🇬🇭Ghana | — | expired | Sept 2026 |
| DOLUTEGRAVIR/LAMIVUDUNE/TENOFOVIR DISOPROXIL FUMARATE TABLETS (Each tablet contains Dolutegravir, Lamivudine and Tenofovir Disoproxil Fumarate 50mg/300mg/300mg) | 🇬🇭Ghana | — | active | Sept 2026 |
| DOLUTEGRAVIR_LAMIVUDINE_AND_TENOFOVIR_DISOPROXIL_FUMARATE 50/300/300MG TABLET TABLET | 🇲🇼Malawi | — | expired | Mar 2025 |
| Dolutegravir, Lamivudine and Tenofovir Disoproxil Fumarate Tablet, coated | 🇹🇿Tanzania | APL Healthcare Limited | active | — |
DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE in Africa — Regulatory Overview
DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE is registered across 4 African markets with 6 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Ghana, Rwanda, Malawi, Tanzania. AfricaRegulatory refreshes this data daily from official government sources.
Of the 6 registrations, 4 (67%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.